JUSTIN TIMMONS: Open Payments
NPI 1093916017 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 11 payments from 7 companies in 2025. Trend: 2023 $133 · 2024 $169 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Dexcom, Inc. | 1 | $24 |
| Itamar Medical Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: CAPLYTA, XIFAXAN, Dexcom G6 Transmitter, WatchPATONE, BREZTRI, JARDIANCE, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
